The discussion reveals the troubling history of oral hypoglycemic drugs, which were initially celebrated for their convenience but came with serious risks, including heart attacks and strokes. A landmark clinical trial from the 1960s exposed that these medications, alongside insulin, failed to improve patient outcomes compared to diet alone. The findings sparked significant controversy, challenging the effectiveness of widely prescribed diabetes treatments.
